Metabolic Syndrome in Patients with Schizophrenia and Bipolar Disorder in a Community Mental Health Center

Metabolic Syndrome in Patients with Schizophrenia and Bipolar Disorder in a Community Mental Health Center

INTRODUCTION[|]The aim of this study was to determine the frequency of metabolic syndrome (MetS) in patients with schizophrenia and bipolar disorder (BD) receiving antipsychotic (AP) medications.[¤]METHODS[|]A total of 207 patients with schizophrenia and BD, diagnosed according to the DSM-IV criteri...

Full description

Bibliographic Details
Main Authors:	Kader Semra Karatas, Bulent Bahceci, Hediye Aktürk, Feride Alakuş
Format:	Article
Language:	English
Published:	KARE Publishing 2019-09-01
Series:	Southern Clinics of Istanbul Eurasia
Subjects:	antipsychotic medications bipolar disorder clinical characteristics;metabolic syndrome;schizophrenia.
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=scie&un=SCIE-05924

Similar Items

Predictors for Antipsychotic Dosage Change in the First Year of Treatment in Schizophrenia Spectrum and Bipolar Disorders
by: Petter Andreas Ringen, et al.
Published: (2019-09-01)

Managing Agitation Associated with Schizophrenia and Bipolar Disorder in the Emergency Setting
by: Scott L. Zeller, MD, et al.
Published: (2016-03-01)

Antipsychotic Effects on Cortical Morphology in Schizophrenia and Bipolar Disorders
by: Ruiqi Feng, et al.
Published: (2020-12-01)

Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults
by: Faden J, et al.
Published: (2019-08-01)

Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: A retrospective cohort study
by: Berger Ariel, et al.
Published: (2012-08-01)

Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
by: Alexander Hodkinson, et al.
Published: (2021-08-01)

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2
by: Sajatovic M, et al.
Published: (2018-06-01)

Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder
by: L. San, et al.
Published: (2017-04-01)

Compare of Executive Function in Bipolar I Disorder and Schizophrenia
by: Mohammad Reza khodaei-Ardakani, et al.
Published: (2013-10-01)

Characterizing the experience of agitation in patients with bipolar disorder and schizophrenia
by: Jenna Roberts, et al.
Published: (2018-04-01)

Morphometry and gyrification in bipolar disorder and schizophrenia: A comparative MRI study
by: Nuno Madeira, et al.
Published: (2020-01-01)

Caregivers burden of patients with schizophrenia and bipolar disorder: A sectional study
by: S Vasudeva, et al.
Published: (2013-01-01)

Treatment of Pediatric Bipolar Disorder
by: Ayten Erdogan, et al.
Published: (2014-06-01)

Treatment of bipolar disorders in older adults: a review
by: Nemanja Ljubic, et al.
Published: (2021-09-01)

Regional brain metabolism in schizophrenia: The influence of antipsychotics
by: Seethalakshmi R, et al.
Published: (2007-01-01)

Investigation of Relationship between Schizophrenia and Bipolar Disorders with Infections Agents
by: Cansu ÖNLEN
Published: (2017-09-01)

Association of metabolic syndrome with schizophrenia
by: Sarita Bajaj, et al.
Published: (2013-01-01)

Prevalence of Tobacco Smoking in Patients with Schizophrenia and Bipolar Disorder in a Portuguese Hospital
by: Joana Lopes, et al.
Published: (2021-03-01)

Comparative study of cytomegalovirus antibody and viral load in schizophrenia and bipolar patients
by: Farid Suleimani Mohammadi, et al.
Published: (2017-02-01)

Relationship between Serum Homocysteine and Metabolic Syndrome among Patients with Schizophrenia and Bipolar Disorder: A Cross Sectional Study
by: Shadi Naderyan Fe'li, et al.
Published: (2020-09-01)

A comparative study of physical activity level among inpatients with schizophrenia and bipolar disorder
by: Shadi Naderyan Fe'li, et al.
Published: (2018-01-01)

The difference in serum proteomes in schizophrenia and bipolar disorder
by: Liudmila Smirnova, et al.
Published: (2019-07-01)

Imaging Habenula Volume in Schizophrenia and Bipolar Disorder
by: Matthew Schafer, et al.
Published: (2018-09-01)

Anticonvulsivantes e antipsicóticos no tratamento do transtorno bipolar Anticonvulsants and antipsychotics in the treatment of Bipolar Disorder
by: Ricardo Alberto Moreno, et al.
Published: (2004-10-01)

Metabolic Syndrome in Schizophrenia: A Non‑systematic Review
by: Marta Nascimento, et al.
Published: (2012-12-01)

Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders?
by: Dara Gammon, et al.
Published: (2021-07-01)

Editorial: Genetic Mechanisms of Biomarkers in Schizophrenia, Bipolar Disorder and Depression
by: Yiguo Tang, et al.
Published: (2021-08-01)

Schizophrenia, bipolar disorder, or intracranial aneurysm? A case report
by: Yifan Shi, et al.
Published: (2021-08-01)

Metabolic disturbances in patients with paranoid schizophrenia treated with atypical antipsychotic drugs
by: Leonid Mikhaylovich Bardenshteyn, et al.
Published: (2010-06-01)

Relapse and hospitalization in patients with schizophrenia and bipolar disorder at the St Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia: a comparative quantitative cross-sectional study
by: Ayano G, et al.
Published: (2017-06-01)

A study on drug attitude among patients with schizophrenia and bipolar affective disorders
by: Sivanandh Budarapu, et al.
Published: (2016-01-01)

A comparative study on metabolic syndrome in patients with schizophrenia treated using first-generation and second-generation antipsychotics
by: Dinesh Panati, et al.
Published: (2020-01-01)

A single blind comparative clinical study of the effects of chlorpromazine and risperidone on positive and negative symptoms in patients of schizophrenia
by: Amrita Prakash Singam, et al.
Published: (2011-01-01)

Stigma and discrimination in patients with schizophrenia and bipolar mood disorder
by: Kanika S Kumar, et al.
Published: (2020-01-01)

Utility of Washington Early Recognition Center (WERC) Self-Report Screening Questionnaires in the Assessment of Patients with Schizophrenia and Bipolar Disorder
by: Christina Jen-Chia Hsieh, et al.
Published: (2016-08-01)

Electroencephalographic Microstates in Schizophrenia and Bipolar Disorder
by: Fanglan Wang, et al.
Published: (2021-02-01)

Update on schizophrenia and bipolar disorder: focus on cariprazine
by: Roberts RJ, et al.
Published: (2016-07-01)

Examination and Comparison of Cognitive and Executive Functions in Patients with Schizophrenia and Bipolar Disorders
by: Behrooz Afshari, et al.
Published: (2019-06-01)

Analysis of the Peripapillary and Macular Regions Using OCT Angiography in Patients with Schizophrenia and Bipolar Disorder
by: Edyta Koman-Wierdak, et al.
Published: (2021-09-01)

Suicide in Schizophrenia: An Educational Overview
by: Leo Sher, et al.
Published: (2019-07-01)